Ali GÜREL, Bilge AYGEN, Hüseyin ÇELİKER, Ayhan DOĞUKAN

İki Haftada Yedi Pulmoner Renal Sendrom Olgusu. RPGN Mevsimi Mi?

Pulmoner renal sendrom genellikle diffüz alveoler hemoraji ve özellikle hızlı ilerleyen glomerulonefrit şeklindeki otoimmün glomerüler tutulumla ortaya çıkar. Hızlı ilerleyen glomerulonefrit ve/ veya pulmoner renal sendromun tedavisi zor olsa da, yüksek doz metilprednizolon, siklofosfamid gibi sitotoksik ajanlar ve plazmaferez hayat kurtarıcı olabilmektedir. Güçlü klinik kuşku varlığında, hastalığın erken dönemlerinde histopatolojik değerlendirme öncesi ve hatta yokluğunda erken tanı ve tedavi gereklidir. Lupus nefriti, Wegener granülomatozisi ve anti nötrofil sitoplasmik antikor ilişkili glomerülonefritlerin mevsimsel ortaya çıkma eğilimleri olduğu bilinmektedir. Farklı hastalıkların bu mevsimsel ortaya çıkma eğilimi, altta yatan patojenik tetikleyici faktörleri yansıtıyor olabilir.Yedi olgumuzun tümü ilkbahar döneminde ve iki haftalık süreç içinde kliniğimize başvurdu. Gözlemlerimiz, hızlı ilerleyen glomerulonefrit ve/ veya pulmoner renal sendromunun mevsimsel ortaya çıkma eğilimi olabileceği yönündedir.

Anahtar Kelimeler:

Hızlı İlerleyen Glomerulonefrit, Pulmoner Renal Sendrom, Mevsim

SEVEN CASES OF PULMONARY- RENAL SYNDROME IN TWO WEEK. IS IT RPGN SEASON?

Pulmonary-renal syndrome (PRS) generally presents with diffuse alveolar haemmorhage (DAH) and autoimmune mediated glomerular involvement especially rapidly progressive glomerulonephritis (RPGN). Although treatment of RPGN and/or PRS is difficult, high dose methylprednisolone, cytotoxic agents such as cyclophosphamide and plasmapheresis can be life saving. Early diagnosis and treatment is necessary even in strong clinical suspicion at early stages of the diseases before or without histopathological evaluation. It is known that lupus nephritis, Wegener’s granulomatosis, anti neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis have seasonal occurance tendency. Seasonal distributions of various diseases may reflect different pathogenic triggers that underly. All seven of our patients were addmitted to our clinic in two week period in early spring season. According to our observations, RPGN and/or pulmonary-renal syndromes may have a seasonal occurance tendency.

Keywords:

Rapidly Progressive Glomerulonephritis, Pulmonary Renal Syndrome, Season,

PDF

___

Couser WG. Rapidly Progressive Glomerulonephritis: Classification, Pathogenetic Mechanisms, and Therapy. Am J Kidney Dis. 1988 Jun;11(6):449-464.
Glassock RJ, Adler SG, Ward HJ, Cohen AH. Primary Glomerular Diseases. In Brenner BM and Rector FC(eds): The Kidney, 4th ed.W.B. Saunders, Philadelphia,1993.
Churg J, Bernstein J, Glassock RJ (eds): Classification Of Glomerular Disease. Renal Disease: Classification and Atlas Of Glomerular Diseases. 2nd ed. New York: Igakushoin Medical; 1995:11.
Hedger N, Stevens J, Drey N, Walker S, Roderick P. Incidence and Outcome Of PauciImmune Rapidly Progressive Glomerulonephritis In Wessex, UK: A 10-Year Retrospective Study. Nephrol Dial Transplant. 2000 Oct;15(10):1593-1599.
West SC, Arulkumaran N, Ind PW, Pusey CD. Pulmonary-Renal Syndrome: A Life Threatening but Treatable Condition. Postgrad Med J. 2013 May;89(1051):274-283.
Gallagher H, Kwan J, Jayne RW: Pulmonary Renal Syndrome: A 4-Year, Single Center Experience. Am J Kidney Dis 2002, 38:42-47.
Goodpasture EW: The Significance Of Certain Pulmonary Lesions In Relation To The Aetiology Of Pneumonia. Am J Med Sci 1919, 158:863-870.
Tanton MC, Tange JD. Goodpasture's Syndrome (Pulmonary Haemorrhage Associated With Glomerulonephritis). Australas Ann Med 1958, 7:132-144.
Bolton WK, Couser WG. Intravenous Pulse Methylprednisolone Therapy Of Acute Crescentic Rapidly Progressive Glomerulonephritis. Am J Med. 1979 Mar;66(3):495502.
Lockwood CM, Rees AJ, Pearson TA, Evans DJ, Peters DK, Wilson CB.Immunosuppression and Plasma-Exchange In The Treatment Of Goodpasture's Syndrome. Lancet. 1976 Apr 3;1(7962):711-715.
Rutgers A, Sanders JS, Stegeman CA, Kallenberg CG. Pauci-Immune Necrotizing Glomerulonephritis. Rheum Dis Clin North Am. 2010 Aug;36(3):559-572.
Kitagawa K, Furuichi K, Shinozaki Y, Toyama T, Kitajima S, Hara A, Iwata Y, Sakai N, Kaneko S, Wada T; Kanazawa Study Group for Renal Diseases and Hypertension. Long-Term Observations Of Clinicopathological Characteristics and Outcome Of Japanese Patients With Pauci-Immune Crescentic Glomerulonephritis. Clin Exp Nephrol. 2013 Apr 10. [Epub ahead of print]
Cruz BA, Ramanoelina J, Mahr A, Cohen P, Mouthon L, Cohen Y, Hoang P, Guillevin L.Prognosis And Outcome Of 26 Patients with Systemic Necrotizing Vasculitis Admitted To The Intensive Care Unit. Rheumatology (Oxford). 2003 Oct;42(10):11831188.
Bouachour G, Roy PM, Tirot P, Guerin O, Gouello JP, Alquier P.Prognosis Of Systemic Diseases Diagnosed In Intensive Care Units. Presse Med. 1996 May 25;25(18):837-841.
Cervera R, Asherson RA, Acevedo ML, Gómez-Puerta JA, Espinosa G, De La Red G, Gil V, Ramos-Casals M, García-Carrasco M, Ingelmo M, Font J.Antiphospholipid Syndrome Associated With Infections: Clinical And Microbiological Characteristics Of 100 Patients. Ann Rheum Dis. 2004 Oct;63(10):1312-1317.
Specks U. Diffuse Alveolar Hemorrhage Syndromes. Curr Opin Rheumatol. 2001 Jan;13(1):12-17.
Collard HR, Schwarz MI.Diffuse Alveolar Hemorrhage. Clin Chest Med. 2004 Sep;25(3):583-592.
Lau KK, Wyatt RJ.Glomerulonephritis. Adolesc Med Clin. 2005 Feb;16(1):67-85.
Bowley NB, Steiner RE, Chin WS.The Chest X-Ray In Antiglomerular Basement Membrane Antibody Disease (Goodpasture's Syndrome). Clin Radiol. 1979 Jul;30(4):419-429.
Papiris SA, Manali ED, Kalomenidis I, Kapotsis GE, Karakatsani A, Roussos C. BenchTo-Bedside Review: Pulmonary-Renal Syndromes--An Update For The Intensivist. Crit Care. 2007;11(3):213.
Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D.Sequential Therapies For Proliferative Lupus Nephritis. N Engl J Med. 2004 Mar 4;350(10):971-980.
Kambham N.Crescentic Glomerulonephritis: An Update On Pauci-Immune And AntiGBM Diseases. Adv Anat Pathol. 2012 Mar;19(2):111-124.
Griffith M, Brett S.The Pulmonary Physician In Critical Care Illustrative Case 3: Pulmonary Vasculitis. Thorax. 2003 Jun;58(6):543-546.
Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, Van der Giessen M, Van der Hem GK, The TH.Autoantibodies Against Neutrophils and Monocytes: Tool For Diagnosis and Marker Of Disease Activity In Wegener's Granulomatosis. Lancet. 1985 Feb 23;1(8426):425-429.
Rihová Z, Jancová E, Merta M, Zabka J, Rysavá R, Bartůnková J, Kolárova I, Tesar V. Daily Oral Versus Pulse Intravenous Cyclophosphamide In The Therapy Of Anca-Associated Vasculitis--Preliminary Single Center Experience. Prague Med Rep. 2004;105(1):64-68.
Gaskin G, Pusey CD.Plasmapheresis In Antineutrophil Cytoplasmic Antibody-Associated Systemic Vasculitis. Ther Apher. 2001 Jun;5(3):176-181.
Schlesinger N, Schlesinger M, Seshan SV. Seasonal Variation Of Lupus Nephritis: High Prevalence Of Class V Lupus Nephritis During The Winter and Spring. J Rheumatol. 2005 Jun;32(6):1053-1057.
Schlesinger N, Schlesinger M.Seasonal Variation Of Rheumatic Diseases. Discov Med. 2005 Feb;5(25):64-69.